The magic of ultrasound imaging enables healthcare professionals to look inside the human body without being invasive.
Diagnostic and Therapeutic Ultrasound Imaging
The National Health Service in England carried out 42.1 million imaging tests in the year to March 2017 compared with 40.7 million in the previous year. Plain X-ray radiography was the most common, with 22.9 million procedures followed by 9.37 million ultrasound scans. In addition, the total of computed tomography scans was 4.82 million compared to 3.36 million magnetic resonance imaging scans.
These imaging modalities demonstrate that ultrasound is more available across a broad spectrum of healthcare services. Ultrasound imaging offers a more cost-effective diagnostic procedure that contributes to the overall diagnosis of the disease state in the patient.
The incorporation of ultrasound imaging in the clinical point-of-care pathway of the patient is to enable the delivery of healthcare products and services in a safe and economical approach compared to traditional X-ray imaging which is not really recommended to be over-used for radiation dosage considerations.
In the last 5 years, many healthcare organisations have made substantial investments in medical ultrasound imaging. This commitment is driven by the advancement of software technology to be able to produce greater accuracy in analysing ultrasound images thereby delivering the best treatment plan for the patient.
The magic of ultrasound imaging enables healthcare professionals to look inside the human body without being invasive. These high-tech ultrasound machines can diagnose and screen for abnormalities to allow a course of treatment and monitoring.
Since the 1960s, ultrasound imaging systems have been widely distributed and used throughout the world, amounting to a yearly use of over a billion scans. These portable ultrasound medical devices have been available since the early start of 2000 and, after a decade, have given way to wireless ultrasound imaging transducers in the form of handheld computers.
Ultrasound Machines
During these past two decades, medical ultrasound imaging has contributed to the advancement of theranostics. For example, in the development of ultrasound machines to be used in elastography, contrast agents, resolution imaging and the application of 2-D array transducers. The imaging modality elastography maps the elastic properties and stiffness of soft tissue.
Elastography aims to determine whether the tissue mass is hard or soft and generates information for a possible cancer diagnosis of certain fibrous tumours. Other applications would include evaluating plaque in an artery during stent implantation. However, elastic characteristics cannot be clearly visualised in general ultrasound images.
To circumvent these issues, the quantitative measure of elasticity can be assisted by using an acoustic radiation force. This force is a physical phenomenon resulting from the interaction of an acoustic wave with an obstacle placed along with its projection. The force exerted on the obstacle is calculated by integrating the acoustic radiation pressure over its surface. This radiation force provides controlled deformation of the target tissue.
An ultrasound imaging transducer implements this action via an algorithm that is accurate to tens of micrometres for the local tissue position. These technologies, combined with a high-frame ultrasound imaging system, can have a frame rate of 10,000/s, providing high-resolution quantitative elastography.
Microbubbles
Other ultrasound technologies use super-resolution imaging by tracking microbubbles in a blood vessel with a high frame system. However, a single microbubble is classed as a scatterer due to the resolution being more elevated than the point spread function of the ultrasound system. The resultant images can provide excellent vasculature networks in the organ. In order to expand ultrasound 3-D imaging, a 2-D array transducer is required, leading to the development of micro-machined sensors.
These 2-D phased array transducers operate in high-intensity focussed ultrasound (HIFU) and can facilitate a response to implement abdominal cancer treatment. Also, this approach can be used to treat brain diseases without craniotomy or burr hole trephination.
Furthermore, MRI guidance systems for brain treatment can be used in conjunction with ultrasound technology to apply a non-invasive selective treatment towards brain-related diseases. This technology platform can deliver results in targeted drug delivery aided by ultrasound and microbubbles.
These microbubbles are generated in the time-variable acoustic pressure field and will undergo oscillation, resulting in the bubbles’ collapse. This process is called acoustic cavitation and occurs close to the temporarily disturbed biological boundary.
Research has demonstrated that ultrasound-mediated drug delivery through the blood-brain barrier has been most successful in animal model experiments. Subsequently, this technology has been extended to targeted brain cancer treatments and other parts of the human body.
Histotripsy
A new ultrasound imaging technique is called histotripsy, in which the tissue structure is subjected to short high-intensity ultrasound pulses. This mechanical fractionation uses an ultrasound intensity several orders higher than conventional diagnostic imaging. The pulse sequence applied is similar to lithotripsy, which is used to break down kidney stones.
The action of histotripsy at the fluid-tissue interface will result in localised tissue removal with appropriate sharp boundaries. This approach has been used to remove cardiac tissue in the treatment of congenital heart disease. However, when applied to bulk tissue, histotripsy results in mechanical fragmentation of the tissue site, leading to liquefication.
Histotripsy has several clinical applications, such as causing defined tissue ablation in the removal of the tumour. This technique provides clear-cut lines between treated tissue and surrounding tissue, unlike HIFU, which uses a thermal effect and produces an irregular boundary. Therefore, histotripsy can be a selective tool for cancer treatment.
Conclusion
Since ultrasound imaging does not involve radiation compared to CT scanning: these new developments in ultrasound technology will in the future become more prevalent in the clinical arena especially in emergency medicine. The ultrasound imaging platform will be the chosen diagnostic tool for cardiology, critical care and anesthesiology.
Ultrasound imaging has become more mobile amongst healthcare professionals by providing a broad range of diagnostic imaging capabilities at the patient’s location. This proven technology offers a fast, high-quality ultrasound examination at the patient’s point of care. These ultrasound technologies bring many advantages towards patient treatment programmes, especially with increased patient safety and clinician efficiency. This can be clearly demonstrated by using the Edge II, which can enhance and accelerate image acquisition to enable clinicians to diagnose the patient’s disease state.
Future developments in ultrasound medical imaging will be to provide cost-effective solutions that do not compromise image quality. The next generation of ultrasound machines will be automated and mobile to enable effective patient diagnosis and treatment planning.
You are here: home » diagnostic medical imaging blog »
